Obesity Clinical Trial
Official title:
Bringing an Evidence-based Nutrition and Exercise Lifestyle Intervention Program (NELIP) for Obese Pregnant Women Into Clinical Practice
This is a pilot project in which investigators will recruit obese (pre-pregnancy BMI of ≥ 35
kg/m2) women from the newly developed "My Clinic" at London Health Sciences Centre as well
as normal obstetrical care at London Health Sciences Centre.
Patients will be randomized to one of three treatment groups: 1) the full Nutrition and
Exercise Lifestyle Intervention Program (NELIP), 2) Nutrition program only, or 3) Exercise
program only.
The investigators hypothesize that the evidence-based NELIP for obese pregnant women will be
feasible to adopt in a clinical setting and will prevent excessive gestational weight gain,
gestational diabetes and promote healthy infant growth patterns at the 6 and 12 month
milestones. Outcomes may be improved in My Clinic over normal obstetrical care patients with
interprofessional services.
Thirty pregnant women (12-16 weeks gestation) with a pre-pregnancy BMI of ≥35 kg/m2 will be
recruited from "My Clinic" and normal obstetrical care.
"My Clinic" is a new outpatient obstetrical care clinic being initiated at London Health
Sciences Centre for obese women. Women in early pregnancy (12-16 weeks) will be recruited
through family physicians' offices from Southwest Ontario to participate in "My Clinic" if
their BMI is > or = 35 at the initiation of pregnancy. The clinic will integrate various
professional groups currently fractured in their provision of care, including ultrasound,
nutrition, social work and obstetrical care to assess and provide care for this group of
women, while providing the patients a group atmosphere for regular counselling during their
scheduled antenatal visits. The clinic will also offer group counseling sessions for
patients covering various topics relating to lifestyle choices including diet and exercise.
Each woman will be screened for medical comorbidities of obesity, including blood pressure
measurements and a fasting oral glucose tolerance test to screen for gestational diabetes.
Once medically pre-screened with no contraindications to walking regularly, each woman will
be approached by a member of the research team. Each woman will record for 3 consecutive
days (including one weekend day) a food intake diary and also record the number of steps
taken during that same time period, using a pedometer with instructions on how to wear it
and record her daily steps. Once these have been returned, the women will be randomized into
one of three groups by computer generated model. The order of randomization will be kept in
the clinic in opaque envelopes and selected by the research assistant after inclusion in the
study is confirmed. The three groups are as described;
1. The NELIP group (N=10) with full intervention (1) will be introduced to a walking
program in which they walk for 25 minutes, 3 to 4 times per week, adding 2 minutes each
week, until 40 minutes is reached and then maintained until delivery. Each woman will
be given a pedometer and log sheet to keep track of daily steps and to initiate
self-monitoring behaviour. The dietary program will mimic the gestational diabetic meal
plan: a) individualize total energy intake with a minimum of 2000 kcal/day (8360
kilojoule/day), taking into account the usual energy intake as indicated by each
dietary assessment (including 3-day food intake records) with a restriction of not more
than 33% total energy intake; b) adjust if necessary the total carbohydrate intake to
40-50% of total energy intake, distributing carbohydrate intake throughout the day with
three balanced meals, and three snacks per day emphasizing complex carbohydrates and
low glycemic index foods; c) adjust the total fat intake to 30% of total energy intake
(substituting monounsaturated fatty acids for saturated and trans-fatty acids), with
the remaining 30% dedicated to protein intake; and d) meet all micronutrient and fluid
needs recommended during pregnancy (2).
2. In order to tease out the effectiveness of the full NELIP, the second group (N=10) will
only be given the exercise component (ELIP) of NELIP. Once dietary intake has been
assessed, this group will not be given any dietary intervention but will be encouraged
to eat a healthy, balanced diet.
3. The third group (N=10) will only be given the nutrition program (NLIP) of NELIP. They
will be encouraged to be more active but will not be given an exercise intervention.
A control group (N=30) will also be recruited from the "My Clinic" and other women
undergoing care through the obstetrical program at London Health Sciences Centre. The women
will be matched by pre-pregnancy BMI, maternal age and parity, with no intervention, but
will attend the clinic for standard obstetric care and follow-up.
Women in groups 1-3 will have weekly weight gain recorded until delivery. Infant gender,
body weight, length, neonatal morphometrics (birth weight:length ratio, BMI, newborn
skinfolds, and circumferences) and placental weight (placenta:birth weight ratio) will be
recorded in all women within 6-18 hours of birth. Any interventions or complications at
birth will also be recorded. At 6 and 12 months post partum, all maternal-infant pairs
(including controls) will be invited to return to the clinic for follow-up. Breast feeding
status, maternal weight retention, infant weight/length/BMI/skinfolds/girths and growth
patterns will be assessed and compared to the WHO Child Growth Standards for infants based
on gender (see above).
All women will complete the Kaiser Physical Activity Questionnaire at entry, 34-36 weeks of
gestation and at each follow-up appointment to track changes in physical activity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |